Vor Biopharma Inc.
A biotechnology company leveraging its expertise in hematopoietic stem cell biology and genome engineering to develop cell therapies combining engineered approaches and targeted therapies for hematological malignancies, including acute myeloid leukemia. The company is developing VOR33, an induced hematopoietic stem cell (eHSCs), and VCAR33, a CAR-T program. Based in Delaware.
Overview
Overview | |
|---|---|
Country | United States |
State | Massachusetts |
Employees | 168 |
Founded | 2015 |
Financials | |
|---|---|
Market Capitalization | 64.85M |
Revenue | |
Operating Income | -127.94M |
Operating Margin | |
Net Income | -120.23M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4900 / 5373 |
Sector : Healthcare | 938 / 1144 |
Industry : Biotechnology | 493 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 4383 / 5565 |
Sector : Healthcare | 777 / 1182 |
Industry : Biotechnology | 428 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4857 / 5436 |
Sector : Healthcare | 935 / 1164 |
Industry : Biotechnology | 497 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 3672 / 5330 |
Sector : Healthcare | 498 / 1174 |
Industry : Biotechnology | 161 / 667 |